Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1236 results for "ranbaxy"

Sun to merge Ranbaxy, to keep brands alive
Deccan Chronicle

Sun to merge Ranbaxy, to keep brands alive

New Delhi: Ranbaxy Laboratories will cease to exist as a company after completion of the $4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets. The Ranbaxy entity will be merged into Sun Pharma and ... Deccan Chronicle, 2 hours ago
[x]  

909 images for ranbaxy

India TV, 6 hours ago
Space View Times, 8 hours ago
NDTV, 14 hours ago
International Business Times UK, 5 days ago
Sify, 6 days ago
Livemint.com, 5 days ago
Bio Spectrum Asia, 4 days ago
Business Line, 1 week ago
MSN Philippines, 1 week ago
Deccan Chronicle, 2 hours ago
Healthcare Finance News

Sun Pharma Acquires Ranbaxy Laboratories

Sun Pharmaceutical Industries Ltd plans to acquire Ranbaxy Laboratories Ltd for US$ 4 billion. The combination of Sun Pharma and Ranbaxy creates the fifth-largest specialty generics company in the world and the largest pharmaceutical company in ...
 Process Worldwide3 days ago Sun Pharmaceutical Industries Ltd to acquire Ranbaxy Laboratories Ltd  International Law Office5 days ago AFP - India-Japan-pharmaceutical-merger-Daiichi-Ranbaxy-Sun  Namibia Press Agency1 week ago 'Accumulate' Sun Pharma; target Rs 646: PL  Myiris1 week ago
[x]  
Finance 24

Investors back Sun Pharma's Ranbaxy move (AFP)

On the surface, Sun Pharma's $US3.2 billion ($A3.42 billion) purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal. But Sun Pharmaceutical Industries' shares ...
 West Australian5 days ago Sun Pharma is able to revive Ranbaxy: investors  China Post6 days ago Investors hail Sun Pharma's Ranbaxy buy  Qatar Peninsula6 days ago 'Sun Pharma can nurse Ranbaxy to health'  Finance 241 week ago
[x]  
Reuters India

Ranbaxy Drugs to be Rebranded as Sun Pharma to Help U.S. Reputation

According to Reuter's sources, Sun Pharmaceutical Industries will begin phasing out sales of generic drugs branded as Ranbaxy Laboratories in the United States, following Sun's $3.2 billion aquisition of Ranbaxy in early April. The rebranding of ...
 Pharmaceutical Manufacturing Magazine2 days ago Sun plans gradual phase-out of ranbaxy-branded drugs in us  4 Traders6 days ago Ranbaxy drugs in US to be phased out  Smart Investor1 week ago Sun To Phase Out Ranbaxy Drugs In US  Businessworld India1 week ago
[x]  
Livemint.com

Ranbaxy, Samsung, Zillow, Scotch: Intellectual Property

A gap in U.S. patent law has kept cheap copies of Novartis AG's (NOVN) heart drug Diovan off the market for 18 months, costing U.S. consumers and insurers as much as $900 million in potential savings. While the Diovan patent expired in September ...
 Bloomberg4 days ago Ranbaxy's Woes Add $900 Million to U.S. Heart Drug Costs  Bloomberg5 days ago Ranbaxy, Samsung, Zillow, Scotch Whisky: Intellectual Property  BusinessWeek4 days ago Ranbaxy's woes add $900 million in costs for heart drug  Livemint.com5 days ago
[x]  
India Today

Sun rises on Ranbaxy

M.G. Arun New Delhi,April 18, 2014| UPDATED15:41 IST Dilip Shanghvi, CEO, Sun Pharmaceutical Industries Ltd. It isn't easy to cast Dilip Shanghvi, 58, Chief Executive Officer of Sun Pharmaceutical Industries Ltd into a classic CEO mould. He ...
 India Today2 days ago
Rediff.com

Ranbaxy buy in line with Sun's strategy

Sun Pharma's recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known for its turnaround talent. In fact, most buyouts by Sun, on ...
 Business Standard4 days ago
[x]  
Business Line

Sun Pharma: BUY

Sun Pharma should be able to sort out Ranbaxy's problems and benefit from its otherwise strong business Despite healthy fundamentals, the stock of Sun Pharma underperformed BSE Healthcare Index since our recommendation in December 2013. This was on account of ...
 Business Line1 week ago
Financial Express

RANBAXY LABORATORIES : Eu exports to remain suspended

04/16/2014 | 02:28am US/Eastern Recommend: 0 The European health regulator European Medicines Agency (EMA) has said on 9 Apr 2014 that Ranbaxy's exports to European Union (EU) countries will remain suspended. The exports from ...
 4 Traders4 days ago RANBAXY LABORATORIES : EU BAN REMAINS ON RANBAXY's 2 PLANTS  4 Traders6 days ago EU ban stays on Ranbaxy's two plants  Business Standard1 week ago Ranbaxy's EU exports to remain suspended  Deccan Herald1 week ago
[x]  

Rising Sun

The takeover of Daiichi Sankyo-owned Ranbaxy, India’s largest pharmaceutical firm, by Sun Pharma in an all-stock deal worth nearly $4 billion is not only the largest deal in pharma in Asia but has catapulted Sun Pharma to becoming the world’s fifth ...
 Asian Age1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less